|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.20 EUR | -.--% |
|
-.--% | +18.82% |
| Market Cap | 38.47M 33.74M 31.15M 28.79M 54.56M 3.68B 55.65M 374M 146M 1.8B 144M 141M 6.26B | P/E 2017 |
17.4x | P/E 2018 | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 36.72M 32.2M 29.73M 27.47M 52.07M 3.52B 53.12M 357M 139M 1.72B 138M 135M 5.97B | EV / Sales 2017 |
1.97x | EV / Sales 2018 | 1.38x |
| Free-Float |
5.42% | Yield 2017 |
3.36% | Yield 2018 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Millet
CEO | Chief Executive Officer | - | 08/12/2002 |
Valérie Chopinet
DFI | Director of Finance/CFO | - | 18/12/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 15/03/1998 | |
Pierre Martin
BRD | Director/Board Member | - | 15/03/1998 |
| Director/Board Member | - | 30/03/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 42.79M | |
| -1.59% | +3.71% | +24.41% | -37.99% | 5.86B | |
| -0.61% | +2.35% | +3.91% | +13.58% | 1.24B | |
| +0.99% | +6.87% | +7.83% | +16.52% | 466M | |
| Average | -0.30% | +4.99% | +12.05% | -2.63% | 1.9B | |
| Weighted average by Cap. | -1.26% | +5.30% | +20.03% | -26.17% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 21.86M 19.17M 17.7M 16.36M 31M 2.09B 31.62M 213M 82.68M 1.02B 82.09M 80.29M 3.56B | 22.21M 19.48M 17.98M 16.62M 31.5M 2.13B 32.13M 216M 84M 1.04B 83.4M 81.58M 3.61B |
| Net income | 2.54M 2.23M 2.06M 1.9M 3.61M 243M 3.68M 24.75M 9.62M 119M 9.55M 9.34M 414M | 1.63M 1.43M 1.32M 1.22M 2.32M 156M 2.36M 15.89M 6.17M 76.5M 6.13M 6M 266M |
| Net Debt | -1.07M -935K -863K -797K -1.51M -102M -1.54M -10.37M -4.03M -49.93M -4M -3.91M -173M | -1.75M -1.54M -1.42M -1.31M -2.49M -168M -2.54M -17.06M -6.63M -82.11M -6.58M -6.44M -285M |
Employees
-
Sector
Drug Retailers
- Stock Market
- Stocks
- ALINN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
